Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Akebia Therapeutics, Inc.

NASDAQ: AKBA · Life Sciences · 5 alerts · CIK 1517022

Share price
$0.4486Close, Nov 16
Market cap
$125M
Shares outstanding
277.66MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Akebia Therapeutics, Inc. filings on SEC EDGAR ↗

7:57 AM ET 8-K
Leadership Change

Akebia Therapeutics Leadership Change

Nicholas Grund, Senior Vice President and Chief Commercial Officer, notified Akebia Therapeutics of his resignation effective November 6, 2026, for personal reasons. Following his departure, Mr. Grund will provide consulting and advisory services to the company through April 30, 2027, under a newly established consulting agreement.

Term
through April 30, 2027

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.